Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z) Other Scholarly Work

Lauko, A, Kotecha, R, Barnett, A et al. (2022). Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases (Scientific Reports, (2021), 11, 1, (18174), 10.1038/s41598-021-97566-z) . 12(1), 10.1038/s41598-022-05489-0

cited authors

  • Lauko, A; Kotecha, R; Barnett, A; Li, H; Tatineni, V; Ali, A; Patil, P; Mohammadi, AM; Chao, ST; Murphy, ES; Angelov, L; Suh, JH; Barnett, GH; Pennell, NA; Ahluwalia, MS

fiu authors

abstract

  • The original version of this Article contained an error in the Funding section. “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.” now reads: “This work was partially funded by the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship F30CA250254 (AL).” The original Article has been corrected.

publication date

  • December 1, 2022

Digital Object Identifier (DOI)

volume

  • 12

issue

  • 1